Literature DB >> 12873818

Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.

Osakuni Morimoto1, Hiroaki Nagano, Masato Sakon, Yoshiyuki Fujiwara, Terumasa Yamada, Hidewaki Nakagawa, Atsushi Miyamoto, Motoi Kondo, Isao Arai, Tameyoshi Yamamoto, Hideo Ota, Keizo Dono, Koji Umeshita, Shoji Nakamori, Yo Sasaki, Osamu Ishikawa, Shingi Imaoka, Morito Monden.   

Abstract

BACKGROUND/AIMS: The prognosis of hepatocellular carcinoma (HCC) is poor because of frequent intrahepatic metastasis (IM) or multicentric carcinogenesis (MC). We compared the effectiveness of loss of heterozygosity (LOH) analysis in the diagnosis of these two forms with that of histopathological diagnosis.
METHODS: Using LOH analysis of 15 specific DNA microsatellite loci, tumor clonality was assessed in 37 cases.
RESULTS: LOH was observed in 30% of seven solitary tumors. According to these results, the selected threshold to diagnose MC was a difference in the LOH status at more than 30% of the analyzed loci, when comparing two samples in the same liver. In nine multiple HCCs, identical genetic and histopathological diagnoses were found in four (IM: 2, MC: 2). Of 21 recurrent tumors, 19 showed LOH for at least one marker. IM and MC were genetically diagnosed in five and ten patients, respectively. Genetic and histopathological diagnoses were identical in ten of 19 patients (IM: 5. MC: 5). Five genetic MC were histopathologically diagnosed as IM (3) and 'undetermined' (2).
CONCLUSIONS: Genetic diagnosis by LOH analysis may be more strict and specific than histopathological diagnosis in the differential diagnosis of IM and MC.

Entities:  

Mesh:

Year:  2003        PMID: 12873818     DOI: 10.1016/s0168-8278(03)00233-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

1.  Wading through the noise of "multi-omics" to identify prognostic biomarkers in hepatocellular carcinoma.

Authors:  Karen Pineda-Solis; Vivian McAlister
Journal:  Hepatobiliary Surg Nutr       Date:  2015-08       Impact factor: 7.293

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

3.  Decoding multifocal hepatocellular carcinoma: an opportune pursuit.

Authors:  György Baffy
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

4.  Distinction of intrahepatic metastasis from multicentric carcinogenesis in multifocal hepatocellular carcinoma using molecular alterations.

Authors:  Peter Chianchiano; Maryam Kherad Pezhouh; Amy Kim; Claudio Luchini; Andrew Cameron; Matthew J Weiss; Jin He; Lysandra Voltaggio; Kiyoko Oshima; Robert A Anders; Laura D Wood
Journal:  Hum Pathol       Date:  2017-11-24       Impact factor: 3.466

Review 5.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

6.  A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.

Authors:  Yukio Tokumitsu; Kazuhiko Sakamoto; Yoshihiro Tokuhisa; Hiroto Matsui; Satoshi Matsukuma; Yoshinari Maeda; Koichiro Sakata; Hiroshi Wada; Hidetoshi Eguchi; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Norio Iizuka; Tomio Ueno; Hiroaki Nagano
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

Review 7.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

8.  Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.

Authors:  Xiaoyun Zhang; Chuan Li; Tianfu Wen; Wei Peng; Lunan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2017-12-14       Impact factor: 3.199

9.  Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.

Authors:  Fuminori Sonohara; Yoshikuni Inokawa; Mitsuhiro Hishida; Mitsuro Kanda; Yoko Nishikawa; Suguru Yamada; Tsutomu Fujii; Hiroyuki Sugimoto; Yasuhiro Kodera; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-10-11       Impact factor: 2.967

10.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.